Medical researchers at the University of Alberta have discovered a drug intended for diabetes appears to restore memory in Alzheimer's brain cells.
Jack Jhamandas, a researcher with the Faculty of Medicine & Dentistry at the U of A, is the principal investigator with the team whose research results were recently published in the peer-reviewed publication The Journal of Neuroscience. He works in the Division of Neurology.
The team took brain tissue from animal models with Alzheimer's disease and tested the tissue in the lab, looking specifically at the cells' memory capacity. When brain cells are shocked by a barrage of electrical impulses, the cells "remember" the experience and this is a typical way to test or measure memory in the lab setting.
Amyloid protein, which is found in abnormally large amounts in the memory and cognition parts of the brains of Alzheimer's patients, diminishes memory. A sister protein, known as amylin, which comes from the pancreas of diabetic patients, has the same impact on memory cells.
Jhamandas and his team demonstrated last year that a diabetes drug that never made it to market, known as AC253, could block the toxic effects of amyloid protein that lead to brain cell death.
In the lab, Jhamandas and his teammates, which included Ryoichi Kimura, a visiting scientist from Japan, tested the memory of normal brain cells and those with Alzheimer's—both from animal models. When the drug AC253 was given to brain cells with Alzheimer's and the shock memory tests were redone, memory was restored to levels similar to those in normal cells.
"This is very important because it tells us that drugs like this might be able to restore memory, even after Alzheimer's disease may have set in," says Jhamandas.
His team is continuing their research in this area and wants to see if the drug, when given before symptoms appear, can "stop the impairment of behaviour and cognition altogether in animals destined to develop Alzheimer's," says Jhamandas. Their continued research tests will take a least a year to complete.
He noted it is difficult for AC253 to cross the brain barrier, so research teams in pharmaceutical companies would need to design a similar drug that is easier to penetrate brain cells. Jhamandas says if the tests are successful, he thinks clinical trials could start within about five years, but he stressed that further testing needs to be done before such trials can occur.
"I think what we discovered may be part of the solution, but I can't say it will be the solution. There is a long list of drugs and approaches that haven't panned out as expected in the fight against Alzheimer's. I don't think one drug or approach will solve Alzheimer's disease because it's a complicated disease, but I am cautiously optimistic about our discovery and its implications."
The Canadian Institutes of Health Research funded the work of Jhamandas and his team.
"An estimated 1,125,000 Canadians will be diagnosed with Alzheimer's over the coming 30 years," said Yves Joanette, Scientific Director of the CIHR Institute of Aging. "To respond to this growing health care challenge, CIHR developed the International Collaborative Research Strategy for Alzheimer's Disease. The strategy aims to give Canadians rapid access to the latest approaches to preventing, diagnosing and treating Alzheimer's Disease and related dementias. The findings by Dr. Jhamandas could eventually help reduce the personal, social and economic impacts for Alzheimer's Disease."
University of Alberta Faculty of Medicine & Dentistry: http://www.med.ualberta.ca
This press release was posted to serve as a topic for discussion. Please comment below. We try our best to only post press releases that are associated with peer reviewed scientific literature. Critical discussions of the research are appreciated. If you need help finding a link to the original article, please contact us on twitter or via e-mail.
Princeton University’s annual science art contest shines a light on the research world, adding a video element this year
Using mitochondrial replacement therapy to create embryos with DNA from three people could have serious consequences Continue reading...
Chinese and Australian scientists find pandas migrate long distances to maintain a balanced diet which helps them breed
On the morning of March 15, 2000, 17 beaked whales stranded themselves on beaches in the northern Bahamas. It was an terrible and extraordinary event: beaked whales are the world's deepest-diving mammals, and these creatures had spent most of their lives in deep undersea canyons.
The UN's seabed authority issues exploration licences that accelerate a search for valuable minerals on the ocean floor.
More than 100 locations on the human genome may play a role in a person’s risk of developing schizophrenia, according to a new study.
The average human today is bigger and lives longer than people at any other time in history
Some bats rely on polarized light to calibrate their internal compass
For one month every summer, hundreds of thousands of purple martins stop by an abandoned shopping mall parking lot in Austin, Texas, on their way to the Amazon Basin. Reporter Luke Quinton visited this year's roosting and offers a glimpse of the phenomenon.
Some, like dolphins or chimps, are sophisticated communicators. But do they have their own languages? Its a question that misses the point